Doug Ross

Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain

William D. Schlaff, Sandra Ann Carson, Anthony A. Luciano et al. · Fertility and Sterility · 2006 · 169 citations · Full text

Medicine, Endocrinology, Gynecology +15

Bone mineral density in women aged 25–35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation

Andrew M. Kaunitz, Paul D. Miller, Valerie Montgomery Rice et al. · Contraception · 2006 · 119 citations

Medicine, Endocrinology, Geriatric Medicine +15

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

György Petrovics, Douglas K. Price, Hong Lou et al. · Prostate Cancer and Prostatic Diseases · 2018 · 64 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg

Raquel De Paz Arias, John K. Jain, Cosima Brucker et al. · Contraception · 2006 · 59 citations

Pharmacy, Pharmacology, Pharmacotherapy +5

Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 ml) contraceptive formulation in asian women

Yeong Cheng Toh, John K. Jain, Mohamad H. Rahnny et al. · Clinical Therapeutics · 2004 · 36 citations

Medicine, Endocrinology, Gynecology +16